Portfolio manager Dan LeVan heads Trivalent, a Boston-based international equity boutique that specializes in non-US developed- and emerging-markets strategies under Victory Capital's umbrella.
In 1978, the first trivalent vaccine included two influenza A strains and one influenza B strain. Currently, there are two influenza B lineages circulating; in the latest WHO recommendations ...
Background Because inactivated trivalent influenza vaccines (TIVs) contain 1 influenza B strain, whereas 2 lineages may co-circulate, B lineage mismatch is frequent. We assessed an inactivated ...
For adults, who have had organ transplants between the ages of 18–64 years, or those on immunosuppressive medications, the shots will include: HD-IIV3 with trivalent high dose inactivated ...
Moderna’s mRNA-1403 is a messenger RNA-based trivalent vaccine candidate designed to protect against multiple norovirus genotypes. Moderna provided an update on the status of its trial investigating a ...
Changes to both schedules include new and updated recommendations for COVID-19 vaccine, change to trivalent influenza vaccines ...
The Fund seeks long-term growth of capital. The Fund invests at least 80% of its assets in securities of small- to mid-capitalization companies.
Portfolio manager Dan LeVan heads Trivalent, a Boston-based international equity boutique that specializes in non-US developed- and emerging-markets strategies under Victory Capital's umbrella.